Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With Hepatitis B Cirrhosis and AKI. | Front Pharmacol | 2022 | 35784735 | PubTator, text mining | PubMed |
| Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma. | Dis Markers | 2022 | 35783014 | PubTator, text mining | PubMed |
| Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease. | Clin Kidney J | 2022 | 35756746 | PubTator, text mining | PubMed |
| Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level. | Nat Commun | 2022 | 35750885 | PubTator, text mining | PubMed |
| High Glycated Hemoglobin Instead of High Body Mass Index Might Increase the Urine N-Acetyl-β-D-glucosaminidase Con-Centration in Children and Adolescents with Diabetes Mellitus. | Life (Basel) | 2022 | 35743910 | PubTator, text mining | PubMed |
| Evaluation of a Maternal Plasma RNA Panel Predicting Spontaneous Preterm Birth and Its Expansion to the Prediction of Preeclampsia. | Diagnostics (Basel) | 2022 | 35741140 | PubTator, text mining | PubMed |
| NAFLD: Mechanisms, Treatments, and Biomarkers. | Biomolecules | 2022 | 35740949 | PubTator, text mining | PubMed |
| Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. | Biomedicines | 2022 | 35740306 | PubTator, text mining | PubMed |
| Research Progress of Safety of Zearalenone: A Review. | Toxins (Basel) | 2022 | 35737047 | PubTator, text mining | PubMed |
LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes. | Contemp Clin Trials Commun | 2022 | 35734220 | PubTator, text mining | PubMed |
| Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma. | Technol Cancer Res Treat | 2022 | 35730194 | PubTator, text mining | PubMed |
| The clinical and pathological relevance of waxy casts in urine sediment. | Ren Fail | 2022 | 35730180 | PubTator, text mining | PubMed |
| Diet evolution of carnivorous and herbivorous mammals in Laurasiatheria. | BMC Ecol Evol | 2022 | 35729512 | PubTator, text mining | PubMed |
| The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft. | Front Pediatr | 2022 | 35722493 | PubTator, text mining | PubMed |
| Three Oxidative Stress-Related Genes That Associate Endometrial Immune Cells Are Considered as Potential Biomarkers for the Prediction of Unexplained Recurrent Implantation Failure. | Front Immunol | 2022 | 35720403 | PubTator, text mining | PubMed |
| Time for Precision Medicine in the Diagnosis of Acute Kidney Injury. | Indian J Crit Care Med | 2022 | 35719446 | PubTator, text mining | PubMed |
| Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease. | Diabetes Metab Res Rev | 2022 | 35708187 | PubTator, text mining | PubMed |
| Soluble IL-33 receptor predicts survival in acute kidney injury. | J Circ Biomark | 2022 | 35707675 | PubTator, text mining | PubMed |
| Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection. | mSystems | 2022 | 35699454 | PubTator, text mining | PubMed |
| Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease. | Front Microbiol | 2022 | 35694307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=41